CAMKMT
Basic information
Region (hg38): 2:44361947-44772592
Previous symbols: [ "C2orf34" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAMKMT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 25 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 2 | 1 |
Variants in CAMKMT
This is a list of pathogenic ClinVar variants found in the CAMKMT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-44362026-G-C | not specified | Uncertain significance (Dec 18, 2023) | ||
2-44362036-C-T | not specified | Uncertain significance (Feb 13, 2023) | ||
2-44362038-G-A | not specified | Uncertain significance (Aug 19, 2023) | ||
2-44362053-G-A | not specified | Uncertain significance (Jun 28, 2022) | ||
2-44362101-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
2-44362111-C-G | not specified | Uncertain significance (Dec 16, 2023) | ||
2-44362125-C-G | not specified | Uncertain significance (Feb 12, 2024) | ||
2-44372753-A-T | not specified | Uncertain significance (Dec 21, 2022) | ||
2-44372761-G-A | not specified | Uncertain significance (Apr 06, 2024) | ||
2-44390243-A-G | not specified | Uncertain significance (Dec 21, 2022) | ||
2-44390245-A-C | not specified | Uncertain significance (Feb 10, 2022) | ||
2-44390272-G-T | not specified | Uncertain significance (Jun 24, 2022) | ||
2-44704291-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
2-44706289-C-A | not specified | Likely benign (Mar 30, 2024) | ||
2-44706336-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
2-44707420-A-G | not specified | Uncertain significance (Jul 27, 2022) | ||
2-44715289-G-T | not specified | Uncertain significance (Jun 29, 2023) | ||
2-44715294-A-T | not specified | Uncertain significance (Oct 29, 2021) | ||
2-44715305-C-T | not specified | Uncertain significance (Oct 16, 2023) | ||
2-44715325-G-A | not specified | Uncertain significance (Aug 05, 2023) | ||
2-44743630-G-A | not specified | Uncertain significance (Oct 06, 2022) | ||
2-44743647-G-T | not specified | Uncertain significance (Jan 04, 2022) | ||
2-44743648-A-G | not specified | Uncertain significance (Nov 14, 2023) | ||
2-44754080-A-G | not specified | Uncertain significance (Dec 21, 2022) | ||
2-44766438-G-A | Likely benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CAMKMT | protein_coding | protein_coding | ENST00000378494 | 11 | 410643 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.38e-15 | 0.00634 | 125694 | 0 | 53 | 125747 | 0.000211 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.137 | 165 | 160 | 1.03 | 0.00000768 | 2090 |
Missense in Polyphen | 30 | 35.97 | 0.83404 | 464 | ||
Synonymous | 0.368 | 56 | 59.6 | 0.939 | 0.00000286 | 611 |
Loss of Function | -0.286 | 22 | 20.6 | 1.07 | 0.00000115 | 237 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000425 | 0.000424 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000545 | 0.000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000203 | 0.000202 |
Middle Eastern | 0.000545 | 0.000544 |
South Asian | 0.000235 | 0.000229 |
Other | 0.000332 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the trimethylation of 'Lys-116' in calmodulin. {ECO:0000269|PubMed:20975703}.;
- Pathway
- Lysine degradation - Homo sapiens (human);Signaling by GPCR;Signal Transduction;Post-translational protein modification;Metabolism of proteins;G alpha (i) signalling events;Protein methylation;Inactivation, recovery and regulation of the phototransduction cascade;The phototransduction cascade;Visual phototransduction;GPCR downstream signalling
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24
Haploinsufficiency Scores
- pHI
- 0.139
- hipred
- N
- hipred_score
- 0.247
- ghis
- 0.581
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Camkmt
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- protein methylation;mitochondrion organization;peptidyl-lysine methylation;regulation of rhodopsin mediated signaling pathway
- Cellular component
- nucleus;cytoplasm;Golgi apparatus;cytosol;protein-containing complex
- Molecular function
- calmodulin-lysine N-methyltransferase activity;heat shock protein binding